General Secretary Xi Jinping pointed out that the development of new productivity is the inherent requirements and important focus point for promoting high-quality development; scientific and technological innovation is the core element of the development of new productivity. Focusing on injecting innovation into the hospital's disciplinary construction and cultivating an innovative culture for the hospital's high-quality development, the “2024 First Qian Qian Forum of Excellence” of the First Affiliated Hospital of Heavy Medicine kicked off in May, which attracted the active participation of experts and scholars in many related domestic specialties, and became an important platform for scholars to share the latest research results, exchange innovative thinking, and enhance academic cooperation. It has become an important platform for scholars to share the latest research results, exchange innovative thinking and enhance academic cooperation.

In order to promote the construction and development of oncology discipline and improve the level of precision diagnosis and treatment of tumors, “The First Qian's Excellence Forum - Frontier Forum on Precision Diagnosis and Treatment of Tumors” was held in the First Affiliated Hospital of Heavy Medicine on May 27th. The forum invited 4 famous domestic experts in the field of oncology to attend and make a wonderful report. Li Jianping, Deputy Secretary of the Party Committee of the First Affiliated Hospital of Heavy Medicine, attended the meeting, and Zhang Tao, Director of Department of Oncology, presided over the meeting.

“The selection of topics for these researches comes from the clinic and finally serves the clinic, so we should be good at discovering problems from clinical practice and solving problems in line with clinical needs.” Sun Jianguo, deputy director of the Department of Oncology, Xinqiao Hospital, Army Medical University, introduced in detail the translational research on reflex lung injury from the aspects of efficacy enhancement of radiotherapy for lung cancer and prevention and control of risk of radiation lung, exploration of radiation lung markers lymphocytes and radiation lung grading, and especially put forward the advanced ways of the optimization strategy of radiation targeting for Stage III NSCLC, the strategy of efficacy enhancement and toxicity reduction of endothelial repressors for radiation lung, and the application of AI digital medicine.

“Multidisciplinary and interdisciplinary diagnosis and treatment is the foundation for the establishment of modern tumor standardized treatment brand.” Chen Jiayi, Director of Radiotherapy Department of Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, introduced the “Ruijin Model” of multidisciplinary diagnosis and treatment of breast cancer, and demonstrated the development and growth process of the radiotherapy department, as well as the painstaking process of “ten years of grinding a sword” from the preparation of the proton radiotherapy instrument to putting it into use. She said, “High-quality prospective research is the soul of the development of the discipline. We should cultivate excellent talents through the construction of the discipline, and give back to the development of the discipline with excellent talents.”

Liu Jiyan, Deputy Director of Department of Tumor Biotherapy, West China Hospital of Sichuan University, suggested that clinical research topics should be designed and carried out from the perspective of clinical phenomena and needs. He shared three scientific research insights: “We should seize the phenomenon, think diligently, think out of the box, think boldly, and work hard to challenge; we should learn by example, learn by example, seize opportunities, actively explore, and scientifically validate; we should study in depth, theoretically deduce, rigorously design, and progress step by step, and clinically translate.” He emphasized the critical importance of details in clinical practice.

“Holding one to eternity, the walker has no boundaries.” The team of Zhang Xi, director of the Hematology Medical Center of Xinqiao Hospital of the Army Medical University, has overcome several medical problems by relying on such firm beliefs, especially in achieving innovative breakthroughs within the field of leukemia bone marrow transplantation. He pointed out that a clear direction for the development of the discipline is half of success, and that the construction of the discipline cannot be separated from the training of talents, and the construction of clinical subspecialty teams and dedicated teams for scientific research is conducive to the promotion of synergistic development of the clinical and basic.

The forum focused on clinical research design and development, multidisciplinary diagnosis and treatment of tumors, precision radiotherapy, subspecialty construction and other aspects of academic exchanges, deepening the scholars' thinking on the development of medical oncology and providing new ideas for the construction of the discipline.